B. Riley Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-77
Closed -$5.93K 1624
2023
Q2
$5.93K Hold
77
﹤0.01% 1532
2023
Q1
$7.18K Hold
77
﹤0.01% 1500
2022
Q4
$7.5K Hold
77
﹤0.01% 1473
2022
Q3
$20K Buy
+77
New +$22.4K ﹤0.01% 1420
2022
Q2
Sell
-203
Closed -$20K 1381
2022
Q1
$20K Hold
203
﹤0.01% 1363
2021
Q4
$33K Sell
203
-1
-0.5% -$220 ﹤0.01% 1383
2021
Q3
$62K Hold
204
﹤0.01% 1366
2021
Q2
$88K Buy
204
+52
+34% +$24.3K ﹤0.01% 1320
2021
Q1
$83K Buy
+152
New +$94.6K ﹤0.01% 1309
2017
Q4
Sell
-154
Closed -$144K 663
2017
Q3
$144K Buy
154
+68
+79% +$60.4K 0.02% 512
2017
Q2
$81K Buy
+86
New +$84.3K 0.01% 506
2016
Q4
Sell
-93
Closed -$79K 636
2016
Q3
$79K Buy
+93
New +$74.8K 0.02% 583
2015
Q1
Sell
-20
Closed -$15 1829
2014
Q4
$15 Buy
+20
New +$10.6K ﹤0.01% 2679
2014
Q3
Sell
-20
Closed -$12.1K 1749
2014
Q2
$12.1K Buy
+20
New +$11.1K ﹤0.01% 1698

Other funds holding TCRT

B. Riley Wealth Advisors's TCRT Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 77 shares — an estimated $5.93K sold.

B. Riley Wealth Advisors first reported a position in TCRT in Q2 2014 and held it in 14 quarters. The position peaked at $144K in Q3 2017. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.

  • B. Riley Wealth Advisors reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 77 Alaunos Therapeutics shares in Q3 2023, an estimated $5.93K.
  • B. Riley Wealth Advisors first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 14 quarters.
  • B. Riley Wealth Advisors's Alaunos Therapeutics position peaked at $144K in Q3 2017.
  • 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.